<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="186">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05158725</url>
  </required_header>
  <id_info>
    <org_study_id>G-EYE/Discovery</org_study_id>
    <nct_id>NCT05158725</nct_id>
  </id_info>
  <brief_title>Comparison of Colonoscopy Adenoma Detection Yield</brief_title>
  <official_title>Comparison of Colonoscopy Adenoma Detection Yield of Standard Colonoscopy, Discovery Aided Colonoscopy, and Discovery and G-EYE® Aided Colonoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Horst Schmidt Klinik GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dr. Horst Schmidt Klinik GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Prospective Randomized Comparison of colonoscopy Adenoma Detection Yield of (i) Standard&#xD;
      Colonoscopy (SC), (ii) artificial intelligence (Discovery) aided colonoscopy, and (iii)&#xD;
      artificial intelligence (Discovery) and permanently mounted balloon (G-EYE®) aided&#xD;
      colonoscopy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multi-center, three-arm, randomized, controlled, open-label study.&#xD;
&#xD;
      Total of up to 1320 patients will be randomized, including up to 10% for subject drop-out,&#xD;
      440 to each of the three following arms (groups):&#xD;
&#xD;
      Group 1 (1st arm): patients will receive standard colonoscopy (SC) Group 2 (2nd arm):&#xD;
      patients will receive colonoscopy aided by the Discovery artificial intelligence software&#xD;
      (DC) Group 3 (3rd arm): patients will receive colonoscopy aided by the Discovery artificial&#xD;
      intelligence software and the G-EYE® balloon (GDC) The purpose of this study is to compare&#xD;
      between the diagnostic yield of Standard Colonoscopy, Discovery aided colonoscopy, and&#xD;
      Discovery &amp; G-EYE® aided colonoscopy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 8, 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Multi-center, three-arm, randomized, controlled, open-label study</intervention_model_description>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adenoma detection yield</measure>
    <time_frame>Upon histology results (up to 30 days)</time_frame>
    <description>adenoma detection yield, represented by Adenoma Per Colonoscopy (APC), of Standard Colonoscopy, compared with APC of Discovery aided colonoscopy and further compared with APC of Discovery &amp; G-EYE® aided colonoscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adenoma Detection Rate (Discovery + G-EYE vs. Standard Colonoscopy)</measure>
    <time_frame>Upon histology results (up to 30 days)</time_frame>
    <description>Adenoma Detection Rate of Discovery and G-EYE® aided colonoscopy compared to Adenoma Detection Rate of Standard Colonoscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adenoma Detection Rate (Discovery vs. Standard Colonosocopy)</measure>
    <time_frame>Upon histology results (up to 30 days)</time_frame>
    <description>Adenoma Detection Rate of Discovery aided colonoscopy compared to Adenoma Detection Rate of Standard Colonoscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adenoma Per Colonoscopy (Discovery vs. Discovery + G-EYE)</measure>
    <time_frame>Upon histology results (up to 30 days)</time_frame>
    <description>Adenoma Per Colonoscopy of Discovery aided colonoscopy compared to Adenoma Per Colonoscopy of Discovery and G-EYE® aided colonoscopy</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">1320</enrollment>
  <condition>Adenoma Colon</condition>
  <arm_group>
    <arm_group_label>Standard Colonoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will undergo colonoscopy using a standard colonoscope</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Discovery aided colonoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will undergo colonoscopy using a a standard colonoscope and the Discovery aided colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Discovery and G-EYE aided colonoscopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will undergo colonoscopy using the G-EYE Endoscope and the Discovery aided colonoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard Colonoscopy</intervention_name>
    <description>In this arm, subjects will undergo colonoscopy using a standard colonoscope</description>
    <arm_group_label>Standard Colonoscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Discovery aided colonoscopy</intervention_name>
    <description>the Discovery is a customized detection support software, developed utilizing AI deep learning technology to support endoscopic lesion detection in the colon. In this arm, a standard colonoscope is used with the Discovery.</description>
    <arm_group_label>Discovery aided colonoscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Discovery and G-EYE</intervention_name>
    <description>The G-EYE® Endoscope is a standard colonoscope which is remanufactured by installing the G-EYE® balloon on the distal bending section of the colonoscope. in this arm, the G-EYE® Endoscope is used with the Discovery</description>
    <arm_group_label>Discovery and G-EYE aided colonoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Screening and surveillance population for Adenoma and CRC.&#xD;
&#xD;
          2. The patient must understand and sign a written informed consent for the procedure.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Subjects with inflammatory bowel disease;&#xD;
&#xD;
          2. Subjects with a personal history of hereditary polyposis syndrome;&#xD;
&#xD;
          3. Subjects with suspected chronic stricture potentially precluding complete colonoscopy;&#xD;
&#xD;
          4. Subjects with diverticulitis or toxic megacolon;&#xD;
&#xD;
          5. Subjects with prior colonic surgery (exclusion appendectomy)&#xD;
&#xD;
          6. Subjects with a history of radiation therapy to abdomen or pelvis;&#xD;
&#xD;
          7. Pregnant or lactating female subjects;&#xD;
&#xD;
          8. Subjects who are currently enrolled in another clinical investigation.&#xD;
&#xD;
          9. Subjects with current oral or parenteral use of anticoagulants, not considered&#xD;
             eligible by the investigator.&#xD;
&#xD;
         10. Subjects with recent (within the last 3 mounts) coronary ischemia or CVA (stroke)&#xD;
&#xD;
         11. Any patient condition deemed too risky for the study by the investigator&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ralf Kiesslich, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helios Dr. Horst Schmidt Kliniken Wiesbaden GmbH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ralf Kiesslich, Prof.</last_name>
    <phone>+49 611 43-9002</phone>
    <email>Ralf.Kiesslich@helios-gesundheit.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Helios Dr. Horst Schmidt Kliniken Wiesbaden GmbH</name>
      <address>
        <city>Wiesbaden</city>
        <zip>65199</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralf Kiesslich, Prof.</last_name>
      <phone>+49 611 43-9002</phone>
      <email>Ralf.Kiesslich@helios-gesundheit.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>December 2, 2021</study_first_submitted>
  <study_first_submitted_qc>December 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 15, 2021</study_first_posted>
  <last_update_submitted>December 2, 2021</last_update_submitted>
  <last_update_submitted_qc>December 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

